Literature DB >> 3115027

Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.

A Perino, P Quartararo, E Catinella, G Genova, E Cittadini.   

Abstract

The effectiveness of a new levo-norgestrel releasing intrauterine device is assessed in fourteen patients with histologically confirmed hyperplastic lesions of the endometrial mucosa. The morphologic response of the hyperplastic endometria to the action of the levo-norgestrel in this study explains the regression of the cases so treated.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Female--indications; Contraceptive Agents, Progestin--indications; Contraceptive Agents--indications; Contraceptive Methods--indications; Diseases; Economic Factors; Endocrine System; Endometrial Effects; Endometrium; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Hormones; Iud; Iud, Hormone Releasing--indications; Levonorgestrel--indications; Physiology; Reproductive Control Agents; Research And Development; Research Methodology; Technology; Treatment; Urogenital Effects; Urogenital System; Uterine Effects; Uterus

Mesh:

Substances:

Year:  1987        PMID: 3115027

Source DB:  PubMed          Journal:  Acta Eur Fertil        ISSN: 0587-2421


  9 in total

Review 1.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

2.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Authors:  Mi-La Kim; Seok Ju Seong
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

Review 4.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  Successful treatment of early endometrial carcinoma by local delivery of levonorgestrel: a case report.

Authors:  D Wildemeersch; E Anderson; K Lambein; P Pauwels; M Dhont
Journal:  Obstet Gynecol Int       Date:  2010-10-20

6.  Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.

Authors:  Paula H Bednarek; Jeffrey T Jensen
Journal:  Int J Womens Health       Date:  2010-08-09

Review 7.  Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview.

Authors:  Giuseppe Gullo; Andrea Etrusco; Gaspare Cucinella; Antonino Perino; Vito Chiantera; Antonio Simone Laganà; Rossella Tomaiuolo; Amerigo Vitagliano; Pierluigi Giampaolino; Marco Noventa; Alessandra Andrisani; Giovanni Buzzaccarini
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 8.  Endometrial hyperplasia as a risk factor of endometrial cancer.

Authors:  Lisa K Nees; Sabine Heublein; Sahra Steinmacher; Ingolf Juhasz-Böss; Sara Brucker; Clemens B Tempfer; Markus Wallwiener
Journal:  Arch Gynecol Obstet       Date:  2022-01-10       Impact factor: 2.493

9.  Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.

Authors:  A Orbo; Ab Vereide; M Arnes; I Pettersen; B Straume
Journal:  BJOG       Date:  2013-11-28       Impact factor: 6.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.